This retrospective study of diabetic patients undergoing non-cardiac surgery has identified that a greater number of patients are at risk of cardiac complications and death in the perioperative period than had previously been suggested. As well as insulin-dependent diabetic patients and patients with elevated creatinine (>178 µmol/l) as previously found, our study suggests that non-insulin-dependent diabetic patients and patients with creatinine >120 µmol/l are also at increased risk of cardiac complications and death following non-cardiac surgery. This increases by a factor of six those diabetic patients at risk of perioperative complications from non-cardiac surgery and also increases the number of patients with renal failure similarly at risk. The study confirms similar risks of cardiac complications and death to other recently published data and suggests ongoing comparisons will contribute to quality assurance activities in anaesthesia and surgery.
Cardiac complications in patients undergoing non-cardiac surgery have been of considerable interest to clinicians for many years, with algorithms developed for calculating the risk of death and serious complications [1] [2] [3] [4] [5] . The contribution of insulin-requiring diabetes and preoperative renal impairment as intermediate risk factors for perioperative cardiac complications has been recognised by the American College of Cardiologists (ACC) and the American Heart Association (AHA) 6 . A recent publication from Denmark has documented the incidence of cardiac complications in both insulin-and non-insulin-requiring diabetic patients aged over 40 years in excess of previous ACC/AHA estimates 7 . Although the Danish study was designed to evaluate the effect of perioperative beta blockade, the failure of these agents to impact perioperative cardiac complications means the study provides a benchmark for comparing these complications between institutions in all diabetic patients 7, 8 . Similarly the recent publication of the POISE study allows a comparison to be made with cardiovascular complications in non-diabetic patients, with risk factors for cardiac complications, undergoing noncardiac surgery 9 .
Given the current numbers and expected increase in diabetes among the Western population, the outcome of diabetic patients from non-cardiac surgery has considerable medical and health economic interest [10] [11] [12] .
We have examined the management and outcomes of both diabetic and non-diabetic patients over 40 years of age undergoing intermediate-and highrisk surgery, as defined by the ACC/AHA 6 , in the Australian tertiary centre of Geelong Hospital.
METHODS
The study integrated data from several databases to identify all diabetic patients over 40 years of age who had undergone intermediate-or high-risk, non-cardiac surgery, defined by the AHA/ACC Guidelines between the dates of 1 January 2005 and 31 December 2006 6 . This selection of dates allowed for a follow-up period of six months. We studied consecutive elective and unscheduled surgery on all diabetics as classified using Australian therapeutic procedures that are based on the International Classification of Disease (ICD-10). The database of diabetic patients contained 596 surgical operations on 531 patients. We also used another data collection to study a larger group of non-diabetic patients undergoing identical surgery with overlapping dates from 1 July to 31 December 2006. This database contained 1126 operations.
Three contiguous databases of laboratory (The BOSS, Core Medical Solutions, Norwood, South Australia), clinical (CORDis, Dynamic Solutions, Preston, Victoria) and administrative (PIMS, iSOFT plc, Banbury, Oxon, United Kingdom) information were interrogated for blood biochemistry, patient episodes and drug prescriptions linked to the same hospital admission for patients using the Barwon Health ID number, which was a unique identifier in the region. Discrepancies between databases and absent data were checked with the original medical record for the surgical admission.
Outcome measures were 30-day mortality and cardiac events. These events were the same in each database analysis and included acute myocardial infarction (as defined by troponin I [cTnI] >1.5 µg/l plus symptoms or electrocardiogram evidence); unstable angina (cTnI >0.11 plus symptoms); acute coronary syndromes (cTnI 0.4 to 1.5); and exacerbations of cardiac failure (cTnI >0.11 plus documented clinical signs or radiological evidence). All-cause mortality at six months was also studied in addition to the composite outcome of mortality and/or a cardiac event for the diabetic patients. Data were stored in a computer spreadsheet. Cox regression analysis was used to identify significant risk factors.
The Geelong Hospital is a unique regional provider in the Barwon Region with the only emergency department handling acute referrals, which is the triage point for all acute cardiac complications. This provided an invaluable advantage in tracking these patients for the six months after surgery.
RESULTS
The surgical subtypes in the diabetic group were vascular 32%; orthopaedics 26.6%; intra-abdominal surgery 23%; urology 10.6% and others 7.8%. Thirty-day mortality and cardiac complication rates for diabetic patients undergoing intermediate-and high-risk surgery were 4.5% mortality, 10.1% cardiac event rate and 12.2% combined event rate. After six months, mortality was 12.6% and the combined event rate was 20%. The same results for the non-diabetic group (30-day mortality and cardiac complication rates) were 3.1% mortality, 5.4% cardiac event rate and 7.3% combined event rate.
The multivariate analyses are shown in Tables 2, 3 and 4. A diabetic patient with renal failure (creatinine >120 µmol/l in the two weeks preceding surgery) is 2.5 times more likely to die or suffer a cardiac complication than a diabetic patient with normal preoperative renal function. Analysis of each outcome indicates that the risk of death for all diabetic patients with renal failure is three times that of diabetics without renal failure and the risk of a cardiac event is 2.2 times higher than diabetics without renal failure. Additionally, diabetic patients >65 years of age are 2.4 times more likely to die or suffer a cardiac complication than diabetic patients aged 40 to 65 years. The increased risk of each separate outcome is 2.7 times for death and 2.1 for cardiac complications with respect to age >65 years.
Analysis of the non-insulin-requiring diabetics shows that patients with preoperative renal failure are 3.8 times more likely to die or suffer a cardiac complication than patients with normal renal function. Mortality is three times higher and the cardiac event rate is 3.9 times that of patients with normal renal function. Non-insulin-requiring diabetic patients aged >65 have a combined event rate of 4.4 times that of patients aged 40 to 65, where the mortality risk is 3.2 and the cardiac event rate is 4.5 times higher than patients aged 40 to 65 years.
Analysis of the insulin-requiring diabetics reveals statistical significance only with respect to the risk factor of preoperative renal failure. The mortality risk in this group of patients is 3.6 times that of insulin-requiring patients with normal renal function and the combined event rate is 4.1 times higher.
This data indicates that for all diabetics there is an increased risk of both death and cardiac complications compared to non-diabetic patients. The risk of death in non-diabetic patients with renal impairment appears higher than in diabetic patients with renal failure, although the cardiac event rate in diabetic patients with renal failure is higher than in non-diabetic patients. 
DISCUSSION
This is the largest outcome analysis of a diabetic population undergoing non-cardiac surgery in Australia so far reported. The population studied included insulin-dependent and non-insulindependent diabetics and the use of 30-day and six-month follow-up data quantifies the continuous nature of the diabetic disease process following an acute episode of care. The risk of death or cardiac events in all diabetic patients was 12.2% at 30 days and 20% at six months after non-cardiac surgery. This progressive increase in complications beyond 30 days emphasises the importance of recognising these events to all clinicians involved in the management of diabetic patients beyond the perioperative period including general practitioners, endocrinologists, cardiologists and general physicians. The study uses troponin I as a marker for myocardial damage and therefore represents a more sophisticated approach to the assessment of cardiac complications than prior studies as suggested by Devereaux and Fleisher and co-workers 6, 13 .
The data from this study were extracted retrospectively from several databases. Although some authors caution against the use of administrative databases to report outcomes, others have found such databases a rich and reliable source of data with an ability to predict the risk of in-hospital mortality equivalent to that of specialist surgical clinical databases 14 . This study confirms the value of database analysis as a source of information in the production of evidence-based guidelines and supports the use of clinical, laboratory and administrative databases in our study [15] [16] [17] .
The retrospective nature of the analysis is not ideal despite the use of case note review in any cases where clarification of database entries was required 18 . The study does show good correlation with the mortality rate of the POISE study, with the non-diabetic patients in our study and the POISE study treatment group both recording a mortality rate of 3.1%; the POISE study control group had a mortality rate of 2.3%, which is lower than any of our groups but may include a Hawthorne effect, which would not have occurred in a retrospective study 19 . However it is still possible that some postoperative cardiac events were not recorded in the database or were omitted from the clinical record, although this is unlikely to have had a significant effect on the results of this study because of the consistent comparison with published results from a prospective, randomised, controlled study 9 . The retrospective study was planned to formulate the design of a prospective study in the same patient group. The study has identified an important and significant area of risk for diabetic patients that will now require prospective studies for further evaluation.
Although there has been considerable debate surrounding the use of beta-blockers in the perioperative management of patients undergoing noncardiac surgery, the recent publication of three randomised studies demonstrating no effect attributable to perioperative beta blockade predicted the results of the POISE study, which did not confirm any beneficial effect from perioperative beta blockade [7] [8] [9] 13, [20] [21] [22] . Similar findings have resulted from trials of regional versus general anaesthesia for non-cardiac surgery, consequently details relating to the anaesthetic technique are unlikely to influence the outcome from surgery and therefore were not analysed in this study 23 .
The most significant factor in diabetic patients that predisposes them to risk of cardiac complications identified by this study is preoperative renal failure. This risk factor has been identified by the ACC/AHA as contributing to an increase in cardiac morbidity and mortality for all patients after non-cardiac surgery 5 . The evidence used to reach this conclusion included two studies of patients undergoing cardiac surgery 24, 25 and a study that validated an index for predicting cardiac risk of major, non-cardiac surgery 26 . The Lee index has since been validated in a European population and is likely to apply to Australian patients 27 . Our data confirm that renal failure is an important risk factor in diabetic patients and contributes significantly to a higher mortality and complication rate in diabetic patients. The hazard ratio of 2.5 (95% confidence interval [CI] 1.7 to 3.7) confirms the highly significant contribution of renal failure to mortality and cardiac events in patients with diabetes 6 .
There are two important new findings from this study. First, the increased level of risk associated with a preoperative raised creatinine applies to a level of renal failure below that identified by Lee and confirmed by Boersma 26, 27 . The serum creatinine used by Lee and Boersma to define renal failure was 178 µmol/l (2 mg/dl). However the strong association between renal failure and cardiac complications or death in this study was observed at a serum creatinine of 120 µmol/l. Second, the definition of diabetes used by Lee and Boersma was patients requiring insulin prior to surgery 26, 27 . This database examines all patients with an ICD-10 diagnosis of diabetes including patients on insulin, oral hypoglycaemic agents and patients on diet control alone. The implications of this finding are enormous, considering that only one-sixth of the patients studied were insulin-dependent. Put another way, the findings here suggest that the increased risk of cardiac complications or death in diabetic patients now applies to a population six times larger than the Lee and Boersma studies and ACC/AHA guidelines indicated 5, 6, 26, 27 . However this finding is in accord with the recent work of Barr and others, which confirmed that the risk of cardiac complications and death of all diabetic patients was increased irrespective of insulin requirement 28 .
The contribution of increasing age to risk of death following non-cardiac surgery observed by other authors is also confirmed in this study 4, 26, 27 . In the combined group the hazard ratio for death with an age >65 years is 2.71 (95% CI 1.46 to 5.05). A similar level of risk with age is seen in the noninsulin-requiring group; hazard ratio 3.23 (95% CI 1.43 to 7.26). The risk of cardiac events and death approached statistical significance in insulinrequiring diabetic patients >65 years of age, (P value 0.052, lower 95% CI 0.99). A larger study is likely to provide the power to confirm this finding.
Similarly, although the contribution of emergency surgery in non-insulin-dependent diabetic patients approached statistical significance for mortality separately (P value 0.051; lower 95% confidence limit 1.00), emergency surgery in this group of patients was significantly associated with the composite outcome of cardiac events and death. This finding confirms the contribution of emergency surgery suggested by the ACC/AHA, but may indicate that emergency surgery on these patients in the Geelong Hospital is appropriately scheduled and supported.
Surgical specialty did not appear to increase the risk of complications or death in our patient group. This confirms the data from a recent Australian prospective observational study of elderly patients (>70 years) undergoing non-cardiac surgery, which identified thoracic surgery as the only surgical specialty contributing to an increased risk of mortality and complications 29 . This study has also identified age, severity of systemic disease (ASA classification) and albumin level as preoperative predictors of postoperative complications, which included 30-day mortality and ICU admission 29 . Although McNichol and co-workers did not identify preoperative renal failure as a risk factor, the development of postoperative renal failure was a statistically significant predictor of 30-day mortality 29 .
The finding of a 20% combined cardiac complication and death rate for all diabetic patients six months after intermediate and major non-cardiac surgery appears higher than previously expected, but underlines the continuous morbidity attributable to diabetes 28 . The increased combined outcome rate in insulin-requiring diabetics of 25% with 18% mortality indicates the magnitude of the contribution from this disease at the time of non-cardiac surgery and the need for careful diabetic control and team management 30, 31 . We plan further studies to examine the contribution of differing management regimens to these patients. The mortality rates quoted are increased over the 30-day mortality rates, which compare favourably with international benchmarks and support the diabetic management protocols used in the Geelong Hospital during the period of the study 7, 32 (see Appendix 1 on the online version; diabetic protocols).
A comparison with recent data from the Danish DiPOM study allows some benchmarking 7 . The DiPOM study was designed to evaluate the effect of metoprolol on the incidence of cardiac complications and death in a diabetic population over 40 years in age. The results for the Danish study indicate a cardiac complication rate of 10%, a mortality rate of 16% and a composite end-point of 20%. However 360 of 921 patients in this trial underwent low risk surgery as classified by the ACC/AHA. This type of surgery carries a risk of <1% mortality 6 . The mortality and complication rates for the Danish study with the Geelong data 7 confirm the ACC/AHA assertion and Lee and Boersma studies that diabetes is a risk factor for cardiac complications following non-cardiac surgery 5, 26, 27 .
We believe that analysis of outcomes is an important contribution to benchmarking clinical activity and that these analyses should be riskadjusted 3, 33, 34 . Such analyses also allow the development of changing mortality and morbidity rates as a monitor of performance and continuous quality improvement. Changes in mortality and morbidity may reflect changes in practice or changes in prevalence of patient characteristics, such as diabetes and renal failure, that impact on outcomes 3, 33 .
This article provides a benchmark for cardiac complications and death at 30 days and six months following intermediate and major non-cardiac surgery on diabetic patients >40 years of age in an Australian tertiary referral centre. This study should be followed by robust prospective analyses of this high-risk patient group and we are planning such studies.
